News & Events

In this section

The Carbon Trust has invested in a novel, low-cost fuel cell architecture which is being commercialised by UCLB and Imperial Innovations. The Carbon Trust is injecting over half a million pounds into a collaboration between UCL and Imperial College to accelerate the commercialisation of an innovative fuel cell. The new technology could help the UK gain a significant share of a fuel cell market estimated by the Carbon... more
UCL spinout company, Abcodia collaborates with Volition Rx to advance the discovery of blood based biomarkers for cancer Abcodia, a biomarker validation company and a UCL spin out company, with investment from UCLB, has today announced a collaboration with life sciences company Volition Rx which will advance the development of biomarkers for the early detection of cancer. The partnership will... more
UCLB patented technology used to develop a potential new treatment for Corneal Surface Disease Researchers at UCL have made a significant advance towards developing a treatment for Corneal Surface Disease, using RAFT TM ; a UCLB patented technology licensed to Tap Biosystems. The development was led by Professor Robert Brown at UCL's Tissue Repair and Engineering Centre... more
UCLB supports venture capital firm MTI to target new investment fund The Orion fund is being launched in a partnership between UCLB, MTI and the technology transfer offices of the Universities of Manchester and Edinburgh. UCLB will work alongside UMI 3 of the University of Manchester and ERI from the University of Edinburgh to identify investment... more
A team of budding student entrepreneurs have won a £500 cash prize, provided by UCLB, in the UCL Apprentice Challenge 2012. The competition, hosted by Ernst & Young at its London headquarters, saw the eight teams of students selected by the UCL Entrepreneurs Society battling it out in a series of challenges to be crowned ultimate victor. The day saw the teams in a frantic dash around... more